vs
Side-by-side financial comparison of GRAPHIC PACKAGING HOLDING CO (GPK) and Zoetis (ZTS). Click either name above to swap in a different company.
Zoetis is the larger business by last-quarter revenue ($2.4B vs $2.1B, roughly 1.1× GRAPHIC PACKAGING HOLDING CO). Zoetis runs the higher net margin — 25.3% vs 3.4%, a 21.9% gap on every dollar of revenue. On growth, Zoetis posted the faster year-over-year revenue change (3.0% vs 0.2%). Over the past eight quarters, Zoetis's revenue compounded faster (4.4% CAGR vs -3.5%).
Graphic Packaging International is a Fortune 500 corporation based in Atlanta, Georgia, United States. It designs and manufactures packaging solutions for commercial products. GPI manufactures paperboard and folding cartons for a wide range of popular consumer goods, particularly beverages and packaged food. The company operates paperboard mills in Kalamazoo, Michigan; Macon, Georgia; Middletown, Ohio; Prosperity, South Carolina; Texarkana, Texas; and West Monroe, Louisiana, that use recycled...
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
GPK vs ZTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.1B | $2.4B |
| Net Profit | $71.0M | $603.0M |
| Gross Margin | 14.1% | 70.2% |
| Operating Margin | 7.4% | 31.9% |
| Net Margin | 3.4% | 25.3% |
| Revenue YoY | 0.2% | 3.0% |
| Net Profit YoY | -48.6% | 3.8% |
| EPS (diluted) | $0.24 | $1.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.1B | $2.4B | ||
| Q3 25 | $2.2B | $2.4B | ||
| Q2 25 | $2.2B | $2.5B | ||
| Q1 25 | $2.1B | $2.2B | ||
| Q4 24 | $2.1B | $2.3B | ||
| Q3 24 | $2.2B | $2.4B | ||
| Q2 24 | $2.2B | $2.4B | ||
| Q1 24 | $2.3B | $2.2B |
| Q4 25 | $71.0M | $603.0M | ||
| Q3 25 | $142.0M | $721.0M | ||
| Q2 25 | $104.0M | $718.0M | ||
| Q1 25 | $127.0M | $631.0M | ||
| Q4 24 | $138.0M | $581.0M | ||
| Q3 24 | $165.0M | $682.0M | ||
| Q2 24 | $190.0M | $624.0M | ||
| Q1 24 | $165.0M | $599.0M |
| Q4 25 | 14.1% | 70.2% | ||
| Q3 25 | 19.6% | 71.5% | ||
| Q2 25 | 18.7% | 73.6% | ||
| Q1 25 | 20.6% | 72.0% | ||
| Q4 24 | 21.4% | 69.5% | ||
| Q3 24 | 22.3% | 70.6% | ||
| Q2 24 | 21.2% | 71.7% | ||
| Q1 24 | 23.0% | 70.6% |
| Q4 25 | 7.4% | 31.9% | ||
| Q3 25 | 10.7% | 37.0% | ||
| Q2 25 | 8.8% | 36.7% | ||
| Q1 25 | 10.5% | 36.5% | ||
| Q4 24 | 11.4% | 31.6% | ||
| Q3 24 | 12.6% | 36.6% | ||
| Q2 24 | 14.5% | 33.0% | ||
| Q1 24 | 12.4% | 34.1% |
| Q4 25 | 3.4% | 25.3% | ||
| Q3 25 | 6.5% | 30.0% | ||
| Q2 25 | 4.7% | 29.2% | ||
| Q1 25 | 6.0% | 28.4% | ||
| Q4 24 | 6.6% | 25.1% | ||
| Q3 24 | 7.5% | 28.6% | ||
| Q2 24 | 8.5% | 26.4% | ||
| Q1 24 | 7.3% | 27.4% |
| Q4 25 | $0.24 | $1.37 | ||
| Q3 25 | $0.48 | $1.63 | ||
| Q2 25 | $0.34 | $1.61 | ||
| Q1 25 | $0.42 | $1.41 | ||
| Q4 24 | $0.46 | $1.29 | ||
| Q3 24 | $0.55 | $1.50 | ||
| Q2 24 | $0.62 | $1.37 | ||
| Q1 24 | $0.53 | $1.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $261.0M | — |
| Total DebtLower is stronger | $5.0B | — |
| Stockholders' EquityBook value | $3.3B | $3.3B |
| Total Assets | $11.8B | $15.5B |
| Debt / EquityLower = less leverage | 1.51× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $261.0M | — | ||
| Q3 25 | $120.0M | $2.1B | ||
| Q2 25 | $120.0M | $1.4B | ||
| Q1 25 | $129.0M | $1.7B | ||
| Q4 24 | $157.0M | $2.0B | ||
| Q3 24 | $126.0M | $1.7B | ||
| Q2 24 | $125.0M | $1.6B | ||
| Q1 24 | $136.0M | $2.0B |
| Q4 25 | $5.0B | — | ||
| Q3 25 | $5.5B | — | ||
| Q2 25 | $5.4B | — | ||
| Q1 25 | $5.7B | — | ||
| Q4 24 | $5.1B | — | ||
| Q3 24 | $5.4B | — | ||
| Q2 24 | $4.9B | — | ||
| Q1 24 | $4.9B | — |
| Q4 25 | $3.3B | $3.3B | ||
| Q3 25 | $3.3B | $5.4B | ||
| Q2 25 | $3.2B | $5.0B | ||
| Q1 25 | $3.2B | $4.7B | ||
| Q4 24 | $3.0B | $4.8B | ||
| Q3 24 | $3.0B | $5.2B | ||
| Q2 24 | $2.8B | $5.0B | ||
| Q1 24 | $2.9B | $5.1B |
| Q4 25 | $11.8B | $15.5B | ||
| Q3 25 | $11.9B | $15.2B | ||
| Q2 25 | $11.8B | $14.5B | ||
| Q1 25 | $11.5B | $14.1B | ||
| Q4 24 | $11.1B | $14.2B | ||
| Q3 24 | $11.2B | $14.4B | ||
| Q2 24 | $10.8B | $14.2B | ||
| Q1 24 | $11.3B | $14.3B |
| Q4 25 | 1.51× | — | ||
| Q3 25 | 1.67× | — | ||
| Q2 25 | 1.68× | — | ||
| Q1 25 | 1.80× | — | ||
| Q4 24 | 1.71× | — | ||
| Q3 24 | 1.79× | — | ||
| Q2 24 | 1.75× | — | ||
| Q1 24 | 1.73× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $521.0M | $893.0M |
| Free Cash FlowOCF − Capex | — | $732.0M |
| FCF MarginFCF / Revenue | — | 30.7% |
| Capex IntensityCapex / Revenue | — | 6.7% |
| Cash ConversionOCF / Net Profit | 7.34× | 1.48× |
| TTM Free Cash FlowTrailing 4 quarters | — | $2.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $521.0M | $893.0M | ||
| Q3 25 | $227.0M | $938.0M | ||
| Q2 25 | $267.0M | $486.0M | ||
| Q1 25 | $-174.0M | $587.0M | ||
| Q4 24 | $489.0M | $905.0M | ||
| Q3 24 | $187.0M | $951.0M | ||
| Q2 24 | $161.0M | $502.0M | ||
| Q1 24 | $3.0M | $595.0M |
| Q4 25 | — | $732.0M | ||
| Q3 25 | — | $805.0M | ||
| Q2 25 | — | $308.0M | ||
| Q1 25 | — | $438.0M | ||
| Q4 24 | — | $689.0M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $370.0M | ||
| Q1 24 | — | $455.0M |
| Q4 25 | — | 30.7% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 12.5% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 29.7% | ||
| Q3 24 | — | 32.8% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | — | 20.8% |
| Q4 25 | — | 6.7% | ||
| Q3 25 | — | 5.5% | ||
| Q2 25 | — | 7.2% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 9.3% | ||
| Q3 24 | — | 7.0% | ||
| Q2 24 | — | 5.6% | ||
| Q1 24 | — | 6.4% |
| Q4 25 | 7.34× | 1.48× | ||
| Q3 25 | 1.60× | 1.30× | ||
| Q2 25 | 2.57× | 0.68× | ||
| Q1 25 | -1.37× | 0.93× | ||
| Q4 24 | 3.54× | 1.56× | ||
| Q3 24 | 1.13× | 1.39× | ||
| Q2 24 | 0.85× | 0.80× | ||
| Q1 24 | 0.02× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GPK
| Americas Paperboard Packaging | $1.4B | 68% |
| Other | $667.0M | 32% |
ZTS
| Other | $1.3B | 56% |
| Livestock | $234.0M | 10% |
| Pain Sedation | $209.0M | 9% |
| Other Pharmaceuticals | $188.0M | 8% |
| Swine | $125.0M | 5% |
| Poultry | $117.0M | 5% |
| Fish | $81.0M | 3% |
| Other Non Pharmaceuticals | $70.0M | 3% |
| Manufactured Product Other | $18.0M | 1% |
| Medicated Feed Additives | $12.0M | 1% |
